Volume 14, Number 3—March 2008
Research
Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City
Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*
Table 2
Site of disease and species of nontuberculous mycobacteria, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003*
| Site of disease | No. patients with MAC infection | No. patients with RGM infection | No. patients with other species infections | Total no. patients (%) |
|---|---|---|---|---|
| Respiratory tract | 65 | 7 | 9 | 81 (68.1) |
| Skin and soft tissue, nonsurgical | 2 | 4 | 6 | 12 (10.1) |
| Surgical sites | 0 | 7 | 2 | 9 (7.6) |
| Bloodstream | 2 | 4 | 1 | 7 (5.9) |
| Lymph node | 5 | 1 | 0 | 6 (5.0) |
| Disseminated | 2 | 0 | 0 | 2 (1.7) |
| Central nervous system | 0 | 1 | 0 | 1 (0.8) |
| Gastrointestinal tract | 0 | 0 | 1 | 1 (0.8) |
| All body sites | 76 | 24 | 19 | 119 (100) |
*MAC, Mycobacterium avium complex; RGM, rapidly growing mycobacteria.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.